Metraipolis › archive › dc_9b4503229bcd

Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant — Europe PMC PMID:41122178

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41122178
DOI
10.3389/fimmu.2025.1664371
License (as archived)
solo-consultazione
Archived
2026-11-09T13:21:30.842Z
SHA-256 of the archived text
116adcb84534588de3d980e4b7e27f34051bf527f3a058130fb276e2c7ca75bc
Stable URL of this page
https://metraipolis.com/documento/dc_9b4503229bcd

How to cite

Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant — Europe PMC PMID:41122178 — Europe PMC (en), https://europepmc.org/article/MED/41122178 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9b4503229bcd (Metraipolis archive dc_9b4503229bcd, sha256 116adcb84534588de3d980e4b7e27f34051bf527f3a058130fb276e2c7ca75bc)
BibTeX
@misc{dc9b4503229bcd,
  title = {Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant — Europe PMC PMID:41122178},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41122178},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9b4503229bcd; sha256 116adcb84534588de3d980e4b7e27f34051bf527f3a058130fb276e2c7ca75bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41122178. Agents can read the archived copy with the MCP tool read_document.